148 related articles for article (PubMed ID: 11686883)
41. Novel
Shaka Z; Mojtabavi H; Rayzan E; Zoghi S; Shahkarami S; Raul JH; Sedighi I; Boztug K; Rezaei N
Allergol Immunopathol (Madr); 2021; 49(2):80-83. PubMed ID: 33641298
[TBL] [Abstract][Full Text] [Related]
42. Distinct Clinical Features and Novel Mutations in Taiwanese Patients With X-Linked Agammaglobulinemia.
Yeh YH; Hsieh MY; Lee WI; Huang JL; Chen LC; Yeh KW; Ou LS; Yao TC; Wu CY; Lin SJ
Front Immunol; 2020; 11():2001. PubMed ID: 33013854
[No Abstract] [Full Text] [Related]
43. Delayed diagnosis in X-linked agammaglobulinemia and its relationship to the occurrence of mutations in BTK non-kinase domains.
Carrillo-Tapia E; García-García E; Herrera-González NE; Yamazaki-Nakashimada MA; Staines-Boone AT; Segura-Mendez NH; Scheffler-Mendoza SC; O Farrill-Romanillos P; Gonzalez-Serrano ME; Rodriguez-Alba JC; Santos-Argumedo L; Berron-Ruiz L; Sanchez-Flores A; López-Herrera G
Expert Rev Clin Immunol; 2018 Jan; 14(1):83-93. PubMed ID: 29202590
[TBL] [Abstract][Full Text] [Related]
44. Bruton's tyrosine kinase is present in normal platelets and its absence identifies patients with X-linked agammaglobulinaemia and carrier females.
Futatani T; Watanabe C; Baba Y; Tsukada S; Ochs HD
Br J Haematol; 2001 Jul; 114(1):141-9. PubMed ID: 11472359
[TBL] [Abstract][Full Text] [Related]
45. [Clinical features of X-linked agammaglobulinemia: analysis of 8 cases].
Wang XC
Zhonghua Er Ke Za Zhi; 2004 Aug; 42(8):564-7. PubMed ID: 15347438
[TBL] [Abstract][Full Text] [Related]
46. [Mutation analysis and prenatal diagnosis in families of X-linked agammaglobulinemia caused by BTK gene mutation].
Kong X; Mo G; Liu N; Tian P; Chen M
Zhonghua Yi Xue Za Zhi; 2014 May; 94(18):1405-8. PubMed ID: 25142992
[TBL] [Abstract][Full Text] [Related]
47. Unimpaired activation of c-Jun NH2-terminal kinase (JNK) 1 upon CD40 stimulation in B cells of patients with X-linked agammaglobulinemia.
Brunner C; Kreth HW; Ochs HD; Schuster V
J Clin Immunol; 2002 Jul; 22(4):244-51. PubMed ID: 12148599
[TBL] [Abstract][Full Text] [Related]
48. DNA-based mutation analysis of Bruton's tyrosine kinase gene in patients with X-linked agammaglobulinaemia.
Vorechovský I; Vihinen M; de Saint Basile G; Honsová S; Hammarström L; Müller S; Nilsson L; Fischer A; Smith CI
Hum Mol Genet; 1995 Jan; 4(1):51-8. PubMed ID: 7711734
[TBL] [Abstract][Full Text] [Related]
49. Optimizing Integration and Expression of Transgenic Bruton's Tyrosine Kinase for CRISPR-Cas9-Mediated Gene Editing of X-Linked Agammaglobulinemia.
Gray DH; Villegas I; Long J; Santos J; Keir A; Abele A; Kuo CY; Kohn DB
CRISPR J; 2021 Apr; 4(2):191-206. PubMed ID: 33876953
[TBL] [Abstract][Full Text] [Related]
50. Identification of Btk mutations in 20 unrelated patients with X-linked agammaglobulinaemia (XLA).
Jin H; Webster AD; Vihinen M; Sideras P; Vorechovsky I; Hammarstróm L; Bernatowska-Matuszkiewicz E; Smith CI; Bobrow M; Vetrie D
Hum Mol Genet; 1995 Apr; 4(4):693-700. PubMed ID: 7633420
[TBL] [Abstract][Full Text] [Related]
51. Screening of genomic DNA to identify mutations in the gene for Bruton's tyrosine kinase.
Conley ME; Fitch-Hilgenberg ME; Cleveland JL; Parolini O; Rohrer J
Hum Mol Genet; 1994 Oct; 3(10):1751-6. PubMed ID: 7849697
[TBL] [Abstract][Full Text] [Related]
52. X-linked agammaglobulinemia in a 10-year-old boy with a novel non-invariant splice-site mutation in Btk gene.
Maekawa K; Yamada M; Okura Y; Sato Y; Yamada Y; Kawamura N; Ariga T
Blood Cells Mol Dis; 2010 Apr; 44(4):300-4. PubMed ID: 20122858
[TBL] [Abstract][Full Text] [Related]
53. Investigation of a synonymous mutation in Btk in a patient with agammaglobulinemia: A case report.
Srinivasan C; Shameli A; Ritchie B; Adatia A
Immun Inflamm Dis; 2023 Oct; 11(10):e1049. PubMed ID: 37904676
[TBL] [Abstract][Full Text] [Related]
54. A novel deletion mutation and structural abnormality in the Bruton's tyrosine kinase gene identified in a Chinese patient with X-linked agammaglobulinemia.
Wang S; Lu Y; Li H; Wang Z; Mo X; Chai Z; Han J
Clin Lab; 2014; 60(5):859-62. PubMed ID: 24839832
[TBL] [Abstract][Full Text] [Related]
55. Genomic organization of the Btk gene and exon scanning for mutations in patients with X-linked agammaglobulinemia.
Hagemann TL; Chen Y; Rosen FS; Kwan SP
Hum Mol Genet; 1994 Oct; 3(10):1743-9. PubMed ID: 7880320
[TBL] [Abstract][Full Text] [Related]
56. Bruton tyrosine kinase (BTK) in X-linked agammaglobulinemia (XLA).
Vihinen M; Mattsson PT; Smith CI
Front Biosci; 2000 Dec; 5():D917-28. PubMed ID: 11102316
[TBL] [Abstract][Full Text] [Related]
57. Identification of a new Bruton's tyrosine kinase (BTK) mutation associated with a mild phenotype in a child with X-linked agammaglobulinemia (XLA).
Staehelin F; Kühne T
Clin Lab Haematol; 2000 Apr; 22(2):123-5. PubMed ID: 10792406
[TBL] [Abstract][Full Text] [Related]
58. X-linked agammaglobulinemia. A clinical and molecular analysis.
Ochs HD; Smith CI
Medicine (Baltimore); 1996 Nov; 75(6):287-99. PubMed ID: 8982147
[TBL] [Abstract][Full Text] [Related]
59. The clinical spectrum of Bruton's agammaglobulinemia.
Stewart DM; Lian L; Nelson DL
Curr Allergy Asthma Rep; 2001 Nov; 1(6):558-65. PubMed ID: 11892085
[TBL] [Abstract][Full Text] [Related]
60. Expression of Bruton's tyrosine kinase in B lymphoblastoid cell lines from X-linked agammaglobulinaemia patients.
De Weers M; Dingjan GM; Brouns GS; Kraakman ME; Mensink RG; Lovering RC; Schuurman RK; Borst J; Hendriks RW
Clin Exp Immunol; 1997 Feb; 107(2):235-40. PubMed ID: 9030858
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
